Can a simple survey help more women get HIV prevention pills?

NCT ID NCT07209722

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study looked at how to make HIV prevention pills (PrEP) more available to women. Researchers surveyed over 1,300 patients and their doctors at gynecology clinics to understand what helps or hinders getting a prescription. The goal was to learn how to better offer PrEP during routine women's health visits.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help design better ways to offer HIV prevention pills to women during routine gynecology visits.

What could go wrong

This is an observational study that only tracked prescriptions and surveyed opinions. It does not test a new drug or prove that any approach works long-term.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREP PRECRIPTIONS FOR REPRODUCTIVE AGED WOMEN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Alabama at Birmingham

    Birmingham, Alabama, 35222, United States